Unknown

Dataset Information

0

Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches.


ABSTRACT: Rifampicin resistance is a major therapeutic challenge, particularly in tuberculosis, leprosy, P. aeruginosa and S. aureus infections, where it develops via missense mutations in gene rpoB. Previously we have highlighted that these mutations reduce protein affinities within the RNA polymerase complex, subsequently reducing nucleic acid affinity. Here, we have used these insights to develop a computational rifampicin resistance predictor capable of identifying resistant mutations even outside the well-defined rifampicin resistance determining region (RRDR), using clinical M. tuberculosis sequencing information. Our tool successfully identified up to 90.9% of M. tuberculosis rpoB variants correctly, with sensitivity of 92.2%, specificity of 83.6% and MCC of 0.69, outperforming the current gold-standard GeneXpert-MTB/RIF. We show our model can be translated to other clinically relevant organisms: M. leprae, P. aeruginosa and S. aureus, despite weak sequence identity. Our method was implemented as an interactive tool, SUSPECT-RIF (StrUctural Susceptibility PrEdiCTion for RIFampicin), freely available at https://biosig.unimelb.edu.au/suspect_rif/ .

SUBMITTER: Portelli S 

PROVIDER: S-EPMC7581776 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches.

Portelli Stephanie S   Myung Yoochan Y   Furnham Nicholas N   Vedithi Sundeep Chaitanya SC   Pires Douglas E V DEV   Ascher David B DB  

Scientific reports 20201022 1


Rifampicin resistance is a major therapeutic challenge, particularly in tuberculosis, leprosy, P. aeruginosa and S. aureus infections, where it develops via missense mutations in gene rpoB. Previously we have highlighted that these mutations reduce protein affinities within the RNA polymerase complex, subsequently reducing nucleic acid affinity. Here, we have used these insights to develop a computational rifampicin resistance predictor capable of identifying resistant mutations even outside the  ...[more]

Similar Datasets

| S-EPMC9307832 | biostudies-literature
2013-01-01 | E-GEOD-29210 | biostudies-arrayexpress
| S-EPMC5435511 | biostudies-literature
| S-EPMC6473276 | biostudies-literature
2013-01-01 | GSE29210 | GEO
| S-EPMC10543087 | biostudies-literature
| S-EPMC7096750 | biostudies-literature
| S-EPMC8657087 | biostudies-literature
| S-EPMC7351018 | biostudies-literature
| S-EPMC6749653 | biostudies-literature